Katlama C - Search Results

1

Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution.

Wirden M, Malet I, Derache A, Marcelin AG, Roquebert B, Simon A, Kirstetter M, Joubert LM, Katlama C, Calvez V. Wirden M, et al. Among authors: katlama c. AIDS. 2005 Mar 24;19(6):630-2. doi: 10.1097/01.aids.0000163942.93563.fd. AIDS. 2005. PMID: 15802984

2

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals.

Buffet R, Agut H, Chieze F, Katlama C, Bolgert F, Devillechabrolle A, Diquet B, Schuller E, Pierrot-Deseilligny C, Gentilini M, et al. Buffet R, et al. Among authors: katlama c. AIDS. 1991 Dec;5(12):1419-24. doi: 10.1097/00002030-199112000-00002. AIDS. 1991. PMID: 1814327

3

Update on opportunistic infections.

Katlama C, Dickinson GM. Katlama C, et al. AIDS. 1993;7 Suppl 1:S185-94. AIDS. 1993. PMID: 8363783 Review. No abstract available.

4

Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.

Katlama C, Mouthon B, Gourdon D, Lapierre D, Rousseau F. Katlama C, et al. AIDS. 1996 Sep;10(10):1107-12. AIDS. 1996. PMID: 8874627 Clinical Trial.

5

Newer nucleosides: lamivudine and stavudine.

Katlama C, Havlir DV. Katlama C, et al. AIDS. 1996;10 Suppl A:S135-43. AIDS. 1996. PMID: 8883621 Review. No abstract available.

6

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.

Molina JM, Goguel J, Sarfati C, Chastang C, Desportes-Livage I, Michiels JF, Maslo C, Katlama C, Cotte L, Leport C, Raffi F, Derouin F, Modaï J. Molina JM, et al. Among authors: katlama c. AIDS. 1997 Nov;11(13):1603-10. doi: 10.1097/00002030-199713000-00009. AIDS. 1997. PMID: 9365765 Clinical Trial.

7

CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.

Mollet L, Sadat-Sowti B, Duntze J, Leblond V, Bergeron F, Calvez V, Katlama C, Debré P, Autran B. Mollet L, et al. Among authors: katlama c. Int Immunol. 1998 Mar;10(3):311-23. doi: 10.1093/intimm/10.3.311. Int Immunol. 1998. PMID: 9576619

8

The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.

Bossi P, Dupin N, Coutellier A, Bricaire F, Lubetzki C, Katlama C, Calvez V. Bossi P, et al. Among authors: katlama c. Clin Infect Dis. 1998 May;26(5):1072-3. doi: 10.1086/520301. Clin Infect Dis. 1998. PMID: 9597227

9

Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis.

Descamps D, Calvez V, Collin G, Cécille A, Apetrei C, Damond F, Katlama C, Matheron S, Huraux JM, Brun-Vézinet F. Descamps D, et al. Among authors: katlama c. J Clin Microbiol. 1998 Jul;36(7):2143-5. doi: 10.1128/JCM.36.7.2143-2145.1998. J Clin Microbiol. 1998. PMID: 9650987 Free PMC article. Clinical Trial.

10

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.

Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Li TS, et al. Among authors: katlama c. Lancet. 1998 Jun 6;351(9117):1682-6. doi: 10.1016/s0140-6736(97)10291-4. Lancet. 1998. PMID: 9734884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

944 results

Search Page

Filters